Eosinophilic pneumonia information and treatment, AEP disease

Eosinophilic pneumonia is a disease involving the immune system and lungs in which eosinophils accumulate in the lung. These white blood cells cause disruption of the normal air spaces (alveoli) where oxygen is extracted from the atmosphere. Several different kinds of eosinophilic pneumonia exist and can occur in any age group.
   Since its original description in 1989, clinicians have documented many cases of AEP.

Eosinophilic pneumonia symptoms
The most common symptoms include cough, fever, difficulty breathing, and sweating at night.

Eosinophilic pneumonia diagnosis
Eosinophilic pneumonia is diagnosed by a combination of characteristic symptoms, findings on a physical examination by a health provider, and the results of blood tests and x-rays.

Eosinophilic pneumonia treatment
Prognosis is excellent once most eosinophilic pneumonia is treated with corticosteroids. We are not aware of natural herbal medicine treatment for this condition at this time.

Prescription Drug induced

Two Cases of Daptomycin-Induced Eosinophilic Pneumonia and Chronic Pneumonitis.
Clin Infect Dis. 2010. Lal Y, Assimacopoulos AP. Academic Assistant Professor, Sanford School of Medicine of the University of South Dakota, Sioux Falls.
We present 2 elderly patients who developed lung infiltrates associated with eosinophilia during intravenous daptomycin treatment. Both patients improved quickly after daptomycin was stopped and steroid treatment was initiated. However, complete recovery did not occur, and both patients became chronically steroid dependent.

Mesalazine therapy
Eosinophilic pneumonia should be considered in patients who develop pulmonary involvement with inflammatory bowel disease receiving mesalazine therapy.

Q. My wife has been diagnosed with chronic eosinophilic pneumonia. We are told that prednisone is the answer to either curing or managing the condition. Are there any natural approaches that can limit or avoid the prednisone route? If not, are there natural approaches to mitigating the less desirable attribute of prednisone?
   A. We have not studied this condition well enough to make any firm recommendations.